7210 Wareham Drive, Tampa, FL 33647
March 19, 2024 Last night Oprah Winfrey hosted a TV special investigating the popular GLP-1 diet drugs. The stories by people who lost significant weight were good, as was the information about obesity being a disease and not just a lack of willpower. However, in our opinion, some very important topics were not even mentioned. […]
Oprah’s TV Special Falls Short Read More »
January 30, 2024 Based on the latest data from the ASMBS (American Society for Metabolic and Bariatric Surgery), the number of surgeries performed jumped by 32% in 2021, to 262,893. This happened during the pandemic, which is surprising, since many elective procedures were postponed. This was about 25% higher than Marketdata’s estimate in our March
Bariatric Surgery Volume Sees Big Increase In 2021 Read More »
January 20, 2024 Novo Nordisk and Eli Lilly aren’t the only drug companies active in the prescription diet drugs space. Viking Therapeutics has a dual GLP-1/GIP agonist in Phase 2 clinical trials for treating obesity and liver fat reduction for injectable and oral administration. Rhythm Pharmaceuticals has an FDA-approved treatment for the treatment of MC4R-pathway-related
More Obesity Drugs In The Pipeline Read More »
January 5, 2023 Eli Lilly and Company launched a website, lillydirect.com, to enable people to directly order from the drug maker including its weight-loss medicine Zepbound as well as connect people with obesity and other conditions with telehealth companies. The service, called LillyDirect, comes on the back on extraordinary demand seen over the last year
Eli Lilly Offers Weight Loss Drug Direct to Consumers Read More »
July 6, 2023 Nutrisystem’s parent company Wellful is reviving the brand this fall in a “convenient direct-to-consumer delivery model,” the company announced Wednesday. Jenny Craig went belly up in May after more than 40 years in business because of growing competition from other diets and the demand for weight loss drugs like Ozempic and Wegovy.
Jenny Craig Gets New Life, Online Read More »
May 1, 2023 According to management: “We’re pleased to see revenue and operating income both ahead of expectations in the quarter, as we continue to adjust to the changing dynamics of the business environment,” said Dan Chard, Medifast’s Chairman & Chief Executive Officer. “Sustainable long-term growth is at the core of our focus, and we are
Medifast Reports 1st Quarter Results Read More »
April 25, 2023 In case you haven’t noticed, literally hundreds of new market research firms have emerged from India in the last 5-10 years, usually headquartered in Pune. Their websites look legit and professional, and they claim to be located in the United States. But, they are usually a one-person operation. Many of these companies
Beware Fake Weight Loss Research From India Read More »
April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With
Noom Is Testing Weight Loss Drugs Read More »
March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The
Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »
January 27, 2023 Ozempic is a medication that’s designed to help manage insulin levels in people with type 2 diabetes. However, it’s recently gotten attention after some people spoke out on social media about using the drug for weight loss. Ozempic, which is a brand name for semaglutide, is currently on the Food and Drug Administration’s list of
“Ozempic Face” Side Effect Read More »